These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32732342)

  • 21. Ophthalmic lymphoma: epidemiology and pathogenesis.
    Sjö LD
    Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
    Aronow ME; Portell CA; Rybicki LA; Sweetenham JW; Singh AD
    Ophthalmology; 2013 Sep; 120(9):1915-9. PubMed ID: 23664470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.
    Graue GF; Finger PT; Maher E; Della Rocca D; Della Rocca R; Lelli GJ; Milman T
    Eur J Ophthalmol; 2013; 23(3):344-55. PubMed ID: 23397158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of ophthalmic lymphoma in Canada during 1992-2010.
    Darwich R; Ghazawi FM; Rahme E; Alghazawi N; Zubarev A; Moreau L; Sasseville D; Burnier MN; Litvinov IV
    Br J Ophthalmol; 2020 Aug; 104(8):1176-1180. PubMed ID: 31722877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular adnexal lymphoproliferative disease: a series of 73 cases.
    McKelvie PA; McNab A; Francis IC; Fox R; O'Day J
    Clin Exp Ophthalmol; 2001 Dec; 29(6):387-93. PubMed ID: 11778809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological Features and Ann Arbor Stage in Periocular Lymphoma.
    Zschoche M; Zimpfer A; Scheef BO; Jünemann AM; Guthoff RF; Junghanss C; Hildebrandt G; Emmert S; Erbersdobler A; Kundt G; Kakkassery V
    In Vivo; 2020; 34(4):1965-1974. PubMed ID: 32606168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.
    Hother C; Rasmussen PK; Joshi T; Reker D; Ralfkiær U; Workman CT; Heegaard S; Ralfkiær E; Grønbæk K
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5169-75. PubMed ID: 23821202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases.
    Coupland SE; Krause L; Delecluse HJ; Anagnostopoulos I; Foss HD; Hummel M; Bornfeld N; Lee WR; Stein H
    Ophthalmology; 1998 Aug; 105(8):1430-41. PubMed ID: 9709754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.
    Sagiv O; Thakar SD; Manning JT; Kandl TJ; Fayad LE; Fowler N; Hagemeister FB; Fanale MA; Pinnix CC; Samaniego F; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):243-246. PubMed ID: 30124609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular adnexal lymphomas: five case presentations and a review of the literature.
    Coupland SE; Hummel M; Stein H
    Surv Ophthalmol; 2002; 47(5):470-90. PubMed ID: 12431695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
    Pei SN; Wang MC; Ma MC; Kuo CY; Liao CK; Qiu H; Rothwell LA; Liu Y
    Sci Rep; 2021 May; 11(1):10069. PubMed ID: 33980914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions.
    Yoon JS; Ma KT; Kim SJ; Kook K; Lee SY
    Ophthalmic Plast Reconstr Surg; 2007; 23(2):94-9. PubMed ID: 17413620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paediatric ocular adnexal lymphoma: a population-based analysis.
    Moustafa GA; Topham AK; Aronow ME; Vavvas DG
    BMJ Open Ophthalmol; 2020; 5(1):e000483. PubMed ID: 32596505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients.
    Sullivan TJ; Whitehead K; Williamson R; Grimes D; Schlect D; Brown I; Dickie G
    Ophthalmic Plast Reconstr Surg; 2005 May; 21(3):177-88. PubMed ID: 15942490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa.
    Nam SW; Woo KI; Kim YD
    Br J Ophthalmol; 2018 Apr; 102(4):502-508. PubMed ID: 28814410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
    Coupland SE
    Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
    Pinnix CC; Dabaja BS; Milgrom SA; Smith GL; Abou Z; Nastoupil L; Romaguera J; Turturro F; Fowler N; Fayad L; Westin J; Neelapu S; Fanale MA; Rodriguez MA; Hagemeister F; Lee HJ; Oki Y; Wang M; Samaniego F; Chi L; Esmaeli B
    Head Neck; 2017 Jun; 39(6):1095-1100. PubMed ID: 28370694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orbital lymphoma.
    Olsen TG; Heegaard S
    Surv Ophthalmol; 2019; 64(1):45-66. PubMed ID: 30144455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases.
    Sharara N; Holden JT; Wojno TH; Feinberg AS; Grossniklaus HE
    Ophthalmology; 2003 Jun; 110(6):1245-54. PubMed ID: 12799255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.